首页> 外文期刊>Journal of Crohn’s & colitis >Sci-B-Vac(TM) Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial
【24h】

Sci-B-Vac(TM) Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial

机译:Sci-B-Vac™与ENGERIX-B疫苗治疗炎性肠病患者的乙型肝炎病毒:一项随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Response rate to second-generation hepatitis B virus vaccines is relatively low in patients with inflammatory bowel diseases compared with the general healthy population. We compared the efficacy and safety of a third- vs a second-generation hepatitis B virus vaccine in a group of patients with inflammatory bowel diseases treated with immunosuppressive medications.
机译:与一般健康人群相比,发炎性肠病患者对第二代乙型肝炎病毒疫苗的应答率相对较低。我们比较了第三代和第二代乙型肝炎病毒疫苗在一组接受免疫抑制药物治疗的炎症性肠病患者中的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号